99%+ HPLC purityThird-party testedCOA with every lot Mass-spec confirmed identityISO/IEC 17025 labsEndotoxin screenedInsured priority shipping · tracked
≥99% PurityPT-141 / Oxytocin / Kisspeptin vialUSA Lab VerifiedISO/IEC 17025

PT-141 / Oxytocin / Kisspeptin

Three-peptide neuroendocrine blend · 20 mg lyophilized

$110.00Out of stock
USA Lab VerifiedISO/IEC 17025:2017View COA

Get an email when PT-141 / Oxytocin / Kisspeptin is back

Leave your email and we will send one note the moment it is back in stock.

One email when it restocks, plus occasional Eon updates. Unsubscribe anytime.

Free Shipping on orders over $200

Secure Checkout
Third-Party Tested
Money-Back Guarantee
PASSEDSterility & Endotoxins
PASSEDNet Content & Purity
Authenticity

Every vial is QR-authenticated

Scan the QR code on any vial to verify its batch, COA, and origin in seconds. Secure traceability from our lab to your bench.

Researchers also added

More to explore.

Research use only.

About this compound

This is a blend. PT-141, Oxytocin and Kisspeptin-10 are combined in a single 20 mg vial, 10 mg, 5 mg and 5 mg respectively. All three are neuroendocrine signalling peptides acting at three unrelated receptors: PT-141 at the melanocortin receptors MC3R and MC4R, Oxytocin at OXTR, and Kisspeptin-10 at KISS1R, where studies have measured hypothalamic signalling down the reproductive hormone axis. The combination has not been characterised as a single formulation.

Melanocortin agonist + neurohypophysial nonapeptide + KISS1R decapeptide

Form
Lyophilized powder blend
Purity
≥99% by HPLC
Vial size
10mg / 5mg / 5mg
Class
Peptide blend
Read the full PT-141 / Oxytocin / Kisspeptin research monograph
Research Snapshot

PT-141 / Oxytocin / Kisspeptin research, by the numbers.

The numbers that define PT-141 / Oxytocin / Kisspeptin and how it is being studied. For laboratory research use only.

  • 3

    Research Peptides

    PT-141 · Oxytocin · Kisspeptin-10

  • 20 mg

    Total Per Vial

    10 mg + 5 mg + 5 mg

  • 3

    Receptor Systems

    MC3R/MC4R · OXTR · KISS1R

  • 4

    Research Areas

    • Melanocortin signalling
    • Neurohormone studies
    • Reproductive axis
How It Works

How PT-141 / Oxytocin / Kisspeptin works

The pathways PT-141 / Oxytocin / Kisspeptin acts on - and what each one does. The animation traces its signal outward from the compound to every target it engages.

Signalling pathways studied in preclinical models · illustrative
Melanocortin Receptors
PT-141

PT-141 is a cyclic heptapeptide that binds MC3R and MC4R. Research has measured its activity in the central nervous system rather than in blood vessels, which separates it from other compounds studied in the same area.

  • Cyclic seven amino acid structure
  • MC3R and MC4R binding
  • Central rather than vascular activity
OXTR Binding
Oxytocin

Oxytocin is a nine amino acid neurohypophysial hormone closed by a disulfide bridge between residues 1 and 6, binding the oxytocin receptor OXTR.

  • Nonapeptide with 1-6 disulfide
  • OXTR agonist
  • Behavioural endpoints in animal models
KISS1R Signalling
Kisspeptin-10

Kisspeptin-10 is the active ten amino acid portion of kisspeptin-54. It binds KISS1R, and studies have measured hypothalamic signalling and how that signal moves down the reproductive hormone axis.

  • Active fragment of kisspeptin-54
  • KISS1R agonist
  • Hypothalamic signalling endpoints
Uses & Applications

What PT-141 / Oxytocin / Kisspeptin is researched for

The main areas PT-141 / Oxytocin / Kisspeptin is being studied for - and the study-reported figures behind them.

Neuro

Melanocortin Signalling

PT-141 is characterised for MC3R and MC4R activity in central nervous system models.

Endocrine

Neurohormone Studies

Oxytocin is a long-established reference ligand for the OXTR receptor.

Endocrine

Reproductive Axis

Kisspeptin-10 is characterised for hypothalamic signalling through KISS1R.

Methods

Parallel Protocols

One vial holds all three peptides under matched handling.

Study-reported magnitudes

Representative figures from published research. Bars fill as you scroll.

PT-141 Melanocortin BindingCharacterised
Oxytocin OXTR PharmacologyWell characterised
Kisspeptin KISS1R SignallingCharacterised
Blend Interaction DataNone

Figures are representative of published research findings and shown for reference.

Molecular Structure

The PT-141 / Oxytocin / Kisspeptin molecule

An interactive 3D model rendered from the compound record - rotate and explore its structure.

Molecular model

Sequence length
blend
Physical form
Lyophilized powder blend
Documented purity
≥99% by HPLC
Compound Information

Full specification

ComponentsPT-141 + Oxytocin + Kisspeptin-10
Content20 mg per vial (10 mg PT-141, 5 mg Oxytocin, 5 mg Kisspeptin-10)
PT-141Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH (bremelanotide)
OxytocinCys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂, CAS 50-56-6
Kisspeptin-10Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂, CAS 374675-21-5
FormLyophilized powder blend
Purity≥99% by HPLC
AppearanceWhite to off-white powder
SolubilityWater-soluble
Storage-20°C, protected from light
ClassificationResearch use only
FAQ

Common questions about PT-141 / Oxytocin / Kisspeptin

All three are neuroendocrine signalling peptides studied in overlapping literature, though at three unrelated receptors: PT-141 at MC3R and MC4R, Oxytocin at OXTR, and Kisspeptin-10 at KISS1R. One vial holds all three under matched handling.

That vial holds 10 mg of each and no Kisspeptin. This one adds Kisspeptin-10 and supplies Oxytocin at 5 mg rather than 10 mg, for the same 20 mg total.

No. Each peptide is characterised separately and no interaction data exists for the combination.

Kisspeptin-10 is the active ten amino acid portion of the longer kisspeptin-54 sequence, and is the form supplied here.

Each lot is analysed by reverse-phase HPLC and released at ≥99%, with a Certificate of Analysis.

Store lyophilized at -20°C for long-term stability, protected from light and moisture, and avoid repeated freeze-thaw cycles.

Research Use Only.

Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.